--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About FBRX20260515C25
Life Science Tools and Services
Forte Biosciences, Inc., is a clinical-stage dermatological company dedicated to the development of living biotherapies FB-401 for the treatment of inflammatory skin diseases. FB-401 has completed phase 1/2 a testing in adults and children (3 years and older) with atopic dermatitis. There is a substantial demand for safe and effective therapies, especially for patients with pediatric atopic dermatitis. Forte plans to advance FB-401 into Phase 2 clinical trials in the mid 2020s.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
